Overview
In an era when the host immunity is heavily leveraged to improve cancer therapy outcomes, it is timely and important to ask whether the aging of the host immunity has an impact on cancer therapy, and vice versa.
Goals of this workshop: Bring immune aging researchers and cancer therapy experts together to understand the current knowledge and research landscape of immune aging on cancer therapy, in addition to identifying the challenges and opportunities in the field.
Targeted audience: Researchers who are interested in understanding the association between cancer therapy and immune aging.
Registration is open (on the Registration webpage).
For any workshop-related questions, please contact: Weiwei Chen, Zhang-Zhi Hu, or Mulualem Tilahun
Planning team:
Weiwei Chen, PhD, NCI; Marc Ernstoff, MD, NCI; Max Guo, PhD, NIA; Zhang-Zhi Hu, PhD, NCI; Mulualem Tilahun, PhD, NIA; Sundar Venkatachalam, PhD, NCI